Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DBTX - Decibel Therapeutics: Gene Therapies For Hearing Loss

DBTX - Decibel Therapeutics: Gene Therapies For Hearing Loss

Decibel Therapeutics Inc.
  • Decibel is a category leader in developing new medicines for hearing and balance disorders.
  • The company's lead asset, DB-OTO, has several upcoming catalysts over the next 18 months that can validate Decibel's platform.
  • With a unique business model, Decibel is a compelling investment positioned to rapidly expand their pipeline and partnerships pending DB-OTO.

For further details see:

Decibel Therapeutics: Gene Therapies For Hearing Loss
Stock Information
Company Name: Decibel Therapeutics Inc.
Stock Symbol: DBTX
Market: NASDAQ
Website: decibeltx.com
Menu
DBTX DBTX Quote DBTX Short DBTX News DBTX Articles DBTX Message Board
Get DBTX Alerts

News, Short Squeeze, Breakout and More Instantly...